1. Ubiquitin, SUMO, and Nedd8 as Therapeutic Targets in Cancer
    Pierre Gâtel et al, 2020, Proteostasis and Disease CrossRef
  2. USP39 mediates p21‐dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis
    Jiahui Yuan et al, 2021, Molecular Carcinogenesis CrossRef
  3. USP39 Serves as a Deubiquitinase to Stabilize STAT1 and Sustains Type I IFN–Induced Antiviral Immunity
    Yihong Peng et al, 2020, The Journal of Immunology CrossRef
  4. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer
    Lin Yan et al, 2019, Cancer Biomarkers CrossRef
  5. Identifying Novel Actionable Targets in Colon Cancer
    Maria Grazia Cerrito et al, 2021, Biomedicines CrossRef
  6. USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma
    Xiao Dong et al, 2021, Cellular Signalling CrossRef
  7. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
    Lucas Cruz et al, 2021, Pharmaceuticals CrossRef
  8. Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer
    Zahra Pezeshkian et al, 2021, Cancers CrossRef
  9. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation
    Kaikai Ding et al, 2019, Oncogene CrossRef
  10. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT
    Congcong Yan et al, 2019, Medical Oncology CrossRef
  11. Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review
    Eman Al-Balushi et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
  12. Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases
    Wenxin Luo et al, 2023, International Immunopharmacology CrossRef
  13. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway
    Lipeng Pei et al, 2024, Apoptosis CrossRef
  14. Long non-coding RNA 520 is a negative prognostic biomarker and exhibits pro-oncogenic function in nasopharyngeal carcinoma carcinogenesis through regulation of miR-26b-3p/USP39 axis
    Tao Xie et al, 2019, Gene CrossRef
  15. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
    Xi Tang et al, 2017, Oncology Reports CrossRef
  16. Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo
    Yongjun Hu et al, 2024, Aging CrossRef
  17. Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma
    Guanen Qiao et al, 2019, International Journal of Molecular Medicine CrossRef
  18. Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
    Jiaqi LIU et al, 2022, Cancers CrossRef
  19. miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway
    Daqiong Jiang et al, 2019, International Journal of Molecular Medicine CrossRef
  20. Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis
    Xinwen Zhang et al, 2024, Current Topics in Medicinal Chemistry CrossRef
  21. USP39 regulates the cell cycle, survival, and growth of human leukemia cells
    Chunxia Liu et al, 2019, Bioscience Reports CrossRef
  22. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2
    Jing Cui et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  23. Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
    Cyrollah Disoma et al, 2022, Biochimie CrossRef
  24. Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)
    Yong Ji et al, 2021, International Journal of Molecular Medicine CrossRef